Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- icovamenibPhase 22 trials
Biomea Fusion Inc. · Type 2 Diabetes
- ICP-723Phase 22 trials
Beijing InnoCare Pharma Tech Co., Ltd. · Advanced Solid Tumors Harboring NTRK Fusion, Primary Central Nervous System Tumors Harboring NTRK Fusion, Solid Tumors
- IDP-121Phase 22 trials
IDP Discovery Pharma S.L. · Small Cell Lung Cancer ( SCLC ), Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- IfetrobanPhase 22 trials
Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited
- IMGN632Phase 22 trials
AbbVie · Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm, Acute Myeloid Leukemia
- IMM01-STEMPhase 22 trials
Immunis, Inc. · Muscle Performance, Sarcopenic Obesity, Muscle Atrophy
- ImzokitugBMS-986340Phase 22 trials
Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer
- INO-5401Phase 22 trials
Inovio Pharmaceuticals · Glioblastoma, Urothelial Carcinoma
- Intracerebroventricular of MT027 UCAR-T Cell targeting B7H3Phase 22 trials
T-MAXIMUM Pharmaceutical Inc · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Brain Metastases From Solid Tumors
- Intravitreal of UltevursenPhase 22 trials
Laboratoires Thea · Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind
- IPG7236Phase 22 trials
Nanjing Immunophage Biotech Co., Ltd · Advanced Solid Tumor, Safety Issues, Tolerability
- IsuzinaxibAPX-115Phase 22 trials
Aptabio Therapeutics, Inc. · Diabetic Kidney Disease (DKD), Contrast Induced Acute Kidney Injury
- itacitinibINCB039110Phase 22 trials
Incyte · B-Cell Malignancies, Lung Cancer
- JAB-8263Phase 22 trials
Jacobio Pharmaceuticals Co., Ltd. · Rheumatoid Arthritis (RA), NSCLC, SCLC
- JMT108Phase 22 trials
Shanghai JMT-Bio Inc. · Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors, Advanced Malignant Tumors
- JNJ-95597528Phase 22 trials
Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma
- JR-446Phase 22 trials
JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis III-B, Mucopolysaccharidosis IIIB
- JS207Phase 22 trials
Mabwell (Shanghai) Bioscience Co., Ltd. · Solid Tumor, Advanced Solid Tumor
- JYP0061Experimental Drug GroupPhase 22 trials
Guangzhou JOYO Pharma Co., Ltd · Moderate-to-severe Atopic Dermatitis, Neuromyelitis Optica Spectrum Disorders
- KB707Phase 22 trials
Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV
- KCBT-1083BEBT-109Phase 22 trials
BeBetter Med Inc · Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
- KDS2010Phase 22 trials
NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients
- KH-001Phase 22 trials
Kadence Bio · Premature Ejaculation, Dentin Hypersensitivity
- KHK4951Phase 22 trials
Kyowa Kirin Co., Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD)
- KL1333NapazimonePhase 22 trials
Pharming Technologies B.V. · Primary Mitochondrial Disease, Mitochondrial Diseases
- KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials
InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer
- KN060Phase 22 trials
Suzhou Alphamab Co., Ltd. · End-Stage Renal Disease Requiring Haemodialysis, Knee Arthroplasty, Total
- LacutoclaxPhase 22 trials
Guangzhou Lupeng Pharmaceutical Company LTD. · Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL)
- LAM-001Phase 22 trials
IRulya Therapeutics Inc. · Sarcoidosis Associated Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia
- LASN01Phase 22 trials
Lassen Therapeutics 1 PTY LTD · Thyroid Eye Disease, Pulmonary Fibrosis, Graves Ophthalmopathy
- LM-168Phase 22 trials
LaNova Medicines Limited · Advanced Solid Tumor, Advanced Solid Tumours
- LM-24C5Phase 22 trials
LaNova Medicines Limited · Advanced Solid Tumor, Advanced Solid Tumor Cancer
- LM-364Phase 22 trials
LaNova Medicines Limited · Advanced Solid Tumor Cancer, Malignant Tumors
- LM103 TILsPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer
- LondamocitinibAZD4604Phase 22 trials
AstraZeneca · Asthma
- LorigerlimabMGD019Phase 22 trials
MacroGenics · Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma
- LS301-ITPhase 22 trials
Integro Theranostics · Non Small Cell Lung Cancer (NSCLC), Breast Cancer, DCIS
- LT3001 DrugPhase 22 trials
Shanghai Pharmaceuticals Holding Co., Ltd · Acute Ischemic Stroke
- LY188011Phase 22 trials
Eli Lilly · Neoplasms, Child, Adolescent
- LY3549492Phase 22 trials
Eli Lilly · Obesity, Overweight
- LY4005130Phase 22 trials
Eli Lilly · Alopecia Areata, Vitiligo, Non-Segmental Vitiligo (NSV)
- LY4395089Phase 22 trials
Eli Lilly · Crohn Disease, Colitis, Ulcerative
- M1774TuvusertibPhase 22 trials
EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer
- matched to VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- matching dosagePhase 22 trials
Hangzhou Sciwind Biosciences Co., Ltd. · Weight Management, Overweight , Obesity, Overweight and/or Obesity
- MBS314Phase 22 trials
Beijing Mabworks Biotech Co., Ltd. · Relapsed or Refractory Multiple Myeloma, Multiple Myeloma
- MenACWYPhase 22 trials
LimmaTech Biologics AG · Shigellosis, Salmonella Infections
- mivelsiranALN-APPPhase 22 trials
Alnylam Pharmaceuticals · Cerebral Amyloid Angiopathy, Down Syndrome-Associated Alzheimer's Disease (DS-AD)
- ML-004Phase 22 trials
MapLight Therapeutics · Autism Spectrum Disorder
- ModzatinibATI-2138Phase 22 trials
Aclaris Therapeutics, Inc. · Lichen Planus, Atopic Dermatitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.